Literature DB >> 8469452

Bone density is compromised in amenorrheic women despite return of menses: a 2-year study.

S Jonnavithula1, M P Warren, R P Fox, M I Lazaro.   

Abstract

OBJECTIVE: To determine the effects of estrogen deprivation on bone mass in young women in whom large bone mass increases are known to occur.
METHODS: Over 2 years, nine amenorrheic and 21 normal women were studied, classified into exercising (dancers) and sedentary subjects. An integrated estrogen exposure score was used to determine estrogen response during the 2 years of study. Bone mineral density was measured by single and dual photon absorptiometry in the spine, wrist, and foot (metatarsus).
RESULTS: Hypoestrogenism was present in all amenorrheic women in the first year, and mean estrogen exposure scores were lower in these subjects during the 2 years. Mean spine, wrist, and metatarsal bone mineral density measurements were lower in the amenorrheic women and remained below the levels in controls, despite changing clinical indices and return of menses in some of the subjects. Amenorrheic dancers showed the greatest increase in spine bone mineral density, gaining 9.65% in the first year, 4.49% in the second, and an increase of 14.43% (P < .05) over the total period. Their bone mineral density values, however, remained significantly below those of normal controls during the duration of the study. The most significant gains were seen in two subjects with weight gain and return of irregular periods (three periods in 12 months).
CONCLUSION: Young amenorrheic exercising women appear to increase bone mass before the return of normal menses; however, bone mass remained below control values during 2 years of study, possibly because of long-term adolescent hypoestrogenism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8469452

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  14 in total

Review 1.  Estrogen replacement therapy and female athletes: current issues.

Authors:  D C Cumming; C E Cumming
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

2.  The pars interarticularis stress reaction, spondylolysis, and spondylolisthesis progression.

Authors:  G Motley; J Nyland; J Jacobs; D N Caborn
Journal:  J Athl Train       Date:  1998-10       Impact factor: 2.860

3.  Bone mineral density in professional female dancers.

Authors:  N Keay; I Fogelman; G Blake
Journal:  Br J Sports Med       Date:  1997-06       Impact factor: 13.800

4.  Irreversible bone loss in former amenorrheic athletes.

Authors:  A D Keen; B L Drinkwater
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 5.  Physical activity in the prevention and amelioration of osteoporosis in women : interaction of mechanical, hormonal and dietary factors.

Authors:  Katarina T Borer
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

Review 6.  Clinical consequences of athletic amenorrhoea.

Authors:  N W Constantini
Journal:  Sports Med       Date:  1994-04       Impact factor: 11.136

7.  Different effects on bone strength and cell differentiation in pre pubertal caloric restriction versus hypothalamic suppression.

Authors:  R N Joshi; F F Safadi; M F Barbe; Fe Del Carpio-Cano; S N Popoff; V R Yingling
Journal:  Bone       Date:  2011-07-23       Impact factor: 4.398

Review 8.  Bone density and young athletic women. An update.

Authors:  David L Nichols; Charlotte F Sanborn; Eve V Essery
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

9.  Factors associated with menstrual dysfunction and self-reported bone stress injuries in female runners in the ultra- and half-marathons of the Two Oceans.

Authors:  L K Micklesfield; J Hugo; C Johnson; T D Noakes; E V Lambert
Journal:  Br J Sports Med       Date:  2007-05-11       Impact factor: 13.800

10.  Gender differences among long-distance backpackers: A prospective study of women Appalachian Trail backpackers.

Authors:  David R Boulware
Journal:  Wilderness Environ Med       Date:  2004       Impact factor: 1.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.